Literature DB >> 22436835

Changes in the prescription of psychotropic drugs in the palliative care of advanced cancer patients over a seven-year period.

Cristina Farriols1, Olivia Ferrández, José Planas, Pere Ortiz, Sergi Mojal, Ada I Ruiz.   

Abstract

CONTEXT: Psychiatric disorders are frequently underdiagnosed and undertreated in advanced cancer patients.
OBJECTIVES: To assess changes in the prescription of psychotropic drugs in terminally ill patients.
METHODS: All patients with advanced disease receiving palliative care between 2002 and 2009 were eligible. The consumption of benzodiazepines, antipsychotics, and antidepressants for the years 2002, 2006, and 2009 was compared. Data on the percentage and profile of psychotropic drugs prescribed were collected.
RESULTS: The study population included 840 patients (241 in 2002, 274 in 2006, and 325 in 2009). The percentage of patients treated with psychotropic drugs increased from 82.2% in 2002 to 90.2% in 2009 (P = 0.006) and the mean number of drugs per patient from 1.66 in 2002 to 2.16 in 2006 (P = 0.003), and to 2.35 in 2009 (P<0.001). Benzodiazepines were prescribed to 72.6% of patients in 2002 and 84% in 2009 (P = 0.001), with lorazepam and midazolam as the most frequently used medications. The use of antipsychotics increased from 26.1% in 2002 to 37.2% in 2006 (P = 0.007) and to 40% in 2009 (P = 0.001), with haloperidol and risperidone as the most commonly prescribed. Antidepressants were prescribed to 17.8% in 2002, 28.1% in 2006 (P = 0.006), and 27.1% in 2009 (P = 0.010), with mirtazapine, citalopram, escitalopram, and duloxetine as the most frequent.
CONCLUSION: Between 2002 and 2009, there was a significant increase in the use of psychotropic drugs and a change in the profile of drugs prescribed.
Copyright © 2012 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22436835     DOI: 10.1016/j.jpainsymman.2011.05.010

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  8 in total

Review 1.  Psychopharmacology in psycho-oncology.

Authors:  Rosangela Caruso; Luigi Grassi; Maria Giulia Nanni; Michelle Riba
Journal:  Curr Psychiatry Rep       Date:  2013-09       Impact factor: 5.285

2.  What type and dose of antidepressants are cancer and non-cancer inpatients being prescribed: a retrospective case-control study at an Australian tertiary hospital.

Authors:  Saira Sanjida; Kelly Mulvogue; Joanne Shaw; Jeremy Couper; David Kissane; Sallie-Anne Pearson; Melanie A Price; Monika Janda
Journal:  Support Care Cancer       Date:  2017-09-19       Impact factor: 3.603

3.  Psychotropic drug dispensing in people with and without cancer in France.

Authors:  Pierre Verger; Sébastien Cortaredona; Marie Tournier; Dominique Rey; Marc-Karim Bendiane; Patrick Peretti-Watel; Hélène Verdoux
Journal:  J Cancer Surviv       Date:  2016-08-23       Impact factor: 4.442

4.  Psychiatric comorbidity among terminally ill patients in general practice in the Netherlands: a comparison between patients with cancer and heart failure.

Authors:  Chong Guan Ng; Ellen Dijkstra; Hugo Smeets; Marco P M Boks; Niek J de Wit
Journal:  Br J Gen Pract       Date:  2013-01       Impact factor: 5.386

5.  Medication use during end-of-life care in a palliative care centre.

Authors:  Anniek D Masman; Monique van Dijk; Dick Tibboel; Frans P M Baar; Ron A A Mathôt
Journal:  Int J Clin Pharm       Date:  2015-04-09

6.  Assessment of Palliative Care in Lung Cancer in Turkey.

Authors:  Y Bülbül; T Ozlu; S Arinc; B A Ozyurek; H Gunbatar; A Senturk; A Bahadir; M Ozcelik; U Yilmaz; M O Akbay; L Saglam; T Kilic; G Kirkil; N Ozcelik; D Tatar; S A Baris; D M Yavsan; H S Sen; S Berk; M Acat; G Cakmak; P F Yumuk; Y S Intepe; U Toru; S O Ayik; I Basyigit; S Ozkurt; L C Mutlu; Z A Yasar; H Esme; M M Erol; O Oruc; Y Erdoğan; S Asker; A Ulas; S Erol; B Kerget; A E Erbaycu; T Teke; M Beşiroğlu; H Can; A Dalli; F Talay
Journal:  Med Princ Pract       Date:  2016-10-24       Impact factor: 1.927

7.  A research study review of effectiveness of treatments for psychiatric conditions common to end-stage cancer patients: needs assessment for future research and an impassioned plea.

Authors:  Ralph J Johnson
Journal:  BMC Psychiatry       Date:  2018-04-03       Impact factor: 3.630

8.  Psychotropic medication utilisation in adult cancer patients in China: A cross-sectional study based on national health insurance database.

Authors:  Lin Bai; Ziyue Xu; Cong Huang; Yunchuan Sui; Xiaodong Guan; Luwen Shi
Journal:  Lancet Reg Health West Pac       Date:  2020-11-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.